Clinical Research Directory
Browse clinical research sites, groups, and studies.
Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Sponsor: Children's Hospital Medical Center, Cincinnati
Summary
The purpose of this multi-centered, NIH-sponsored study is to to develop an optimal protocol for using non-invasive 129Xe gas exchange MRI to detect changing disease activity in interstitial lung diseases (ILDs). We base this study on the demonstrated promise of 129Xe as a biomarker for both prognosis and therapy response, overwhelming interest from both industry and academic partners, and impending FDA approval for 129Xe ventilation MRI. This requires disseminating standardized and repeatable methods for 3D 129Xe functional MRI in order to facilitate innovative multi-center observational and interventional trials that can advance our understanding of fibrotic lung disease, while accelerating the development of novel therapies.
Official title: Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
78
Start Date
2022-04-14
Completion Date
2027-12-30
Last Updated
2026-02-13
Healthy Volunteers
Yes
Conditions
Interventions
Xenon-129
Inhaled contrast for MRI
Locations (1)
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States